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Prior to the introduction of Part D in 2006, beneficiaries obtained coverage through a patchwork of supplemental private and public programs, with varying eligibility requirements and levels of coverage. 2 At any given time, one-third of all beneficiaries lacked drug benefits. 3 The combination of no coverage and very restricted benefits for certain types of drug plans, particularly Medicare health maintenance organizations (HMOs) and Medicare supplemental, or Medigap, plans, placed out-of-pocket burdens on beneficiaries. It also resulted in nonadherence, or not taking drugs as prescribed, because of the cost burden on many beneficiaries who had limited incomes and multiple chronic conditions. 4, 5 The evidence indicates that Part D was largely successful in enrolling beneficiaries who lacked prior drug coverage. By the end of 2006, approximately 53 percent of beneficiaries were enrolled in Part D plans, and an additional 37 percent had some other form of coverage. That left only 10 percent of beneficiaries with no drug coverage. 6 However, the situation was not so encouraging for low-income beneficiaries. According to government estimates, 13-14.2 million beneficiaries in 2006 were eligible for the special lowincome subsidy accompanying Part D, known as "Extra Help." Of these, 7.5 million were Medicare dual eligibles-eligible for both Medicaid and Medicare coverage-who were automatically enrolled in Part D plans that bid to provide the coverage at attractive premium levels. Among the 5.5-6.5 million non-dually eligible beneficiaries thought to be eligible for the subsidy, 35-42 percent enrolled in the program. A small but unknown number is thought to have enrolled in Part D without the low-income subsidy, and another half-million are thought to have obtained other sources of drug coverage. 1, 7 Thus, two to three million low-income beneficiaries remained without prescription benefits in 2006.
In this study we used data from the Medicare Current Beneficiary Survey (MCBS) to examine 2006 participation rates in Part D among beneficiaries who had no evidence of drug coverage in 2005. We produced separate estimates for total Part D enrollment and low-income subsidy coverage among low-income beneficiaries. We used bivariate and multivariate techniques to identify the roles of income, chronic disease, and other beneficiary characteristics as determinants of participation.
Although there is a growing literature on overall enrollment patterns in Part D, we believe that this is the first study to analyze Part D participation among previously uncovered beneficiaries. This population group was a key concern for policy makers, so information about the characteristics of those who enrolled, and those who remained without coverage, will help inform future Medicare policies regarding the wisdom of voluntary coverage decisions. We pay particular attention to income, to shed light on the question of why such a large number of beneficiaries potentially eligible for the subsidy failed to enroll. The same basic procedure, with the addition of the monthly Part D enrollment indicators, was used to determine whether sample subjects had drug coverage at the time of the fall 2006 Access to Care survey. We used the retiree drug subsidy administrative enrollment indicator in the MCBS to supplement self-reported information on employer-sponsored drug coverage. To address multiple sources of drug coverage, we used a hierarchical assignment, so that beneficiaries with any Part D enrollment were assigned to Part D; beneficiaries without Part D but with private coverage were assigned to that category; and beneficiaries without Part D or private coverage, but with other sources of public coverage, were assigned to a third category.
Study Data And Methods
Other Measures We created a series of baseline 2005 variables likely to influence beneficiaries' decisions to enroll in Part D. Because of the low-income subsidy provisions in the law, we defined income in relation to the federal poverty level, using 2005 federal poverty-level thresholds for single and married elderly people. For some analyses we created a subset of low-income beneficiaries defined as having incomes less than 150 percent of poverty. This criterion parallels the income eligibility threshold for the low-income subsidy. We were unable to identify beneficiaries who met all subsidy eligibility requirements because the MCBS lacks data on assets.
We measured chronic disease using eleven self-reported indicators, including emphysema/ chronic obstructive pulmonary disease, cancer, diabetes, rheumatoid arthritis, osteoarthritis, prostate disease, depression, heart failure, cardiac arrhythmias, cognitive disorders (a composite of memory loss and Alzheimer's disease), and vascular disease (a composite of cardiovascular disease, stroke, and myocardial infarction). We created counts of these conditions. We used two measures to assess pre-Part D financial effects of high drug costs. The first is "hardship," an indicator that the beneficiary cut back on other spending to pay for drugs. The second measure is "cost-related nonadherence," defined as follows: The beneficiary went without a needed prescription drug due to cost or because insurance would not cover it, or skipped doses or split pills "sometimes" or "often" to make the prescription last longer.
We also created a composite measure to identify the most vulnerable beneficiaries, based on their reporting either five or more chronic conditions or either of the financial hardship measures. We did not incorporate income into our vulnerability measure, but we note that 50 percent of the vulnerable group had incomes under 150 percent of poverty.
Recognizing that Part D enrollment was likely to vary by beneficiaries' demographic characteristics, we included age, sex, race/ethnicity, marital status, educational attainment, urban/ rural residence, and census region as variables. We also expected Part D participation to vary based on whether the beneficiary had supplemental coverage from an employer, Medigap, or Medicare Advantage plan without drug benefits.
Finally, we included a measure of the lowest Part D plan premium offered in 2006 in the state of residence, expecting higher non-low-income subsidy participation rates in areas with less expensive Part D plans, and higher rates of lowincome subsidy participation in areas with higher Part D plan premiums, as the relative value of the low-income subsidy is higher in higher-premium areas.
Statistical Analysis Our first step was to compare the presence and type of prescription drug coverage in 2006 for the targeted subgroup with no drug coverage in 2005.We used bivariate and multivariate methods to examine the relationship of beneficiaries' health status and other characteristics to Part D enrollment and to enrollment in the low-income subsidy among low-income beneficiaries. Finally, we examined Part D and low-income subsidy participation rates, stratifying based on our composite indicator for vulnerable beneficiaries, and we examined reasons for failure to enroll in 2006.
The multivariate models were estimated using logistic regression, with coefficients transformed to conditional marginal probabilities of Part D (or low-income subsidy) enrollment. All estimates were weighted to be nationally representative of the noninstitutionalized Medicare population. Standard errors were adjusted for the complex survey design of the Medicare Current Beneficiary Survey. Analyses were performed using the statistical software SAS version 9.1 and Stata version 10. Characteristics Associated With Enrollment In Part D Exhibit 2 presents beneficiary characteristics, unadjusted rates of Part D participation by beneficiary characteristics, and conditional marginal probabilities of participation, among beneficiaries without drug coverage in 2005. In the unadjusted comparisons, participation rates were lower for disabled beneficiaries ages 50-64, males, urban dwellers, and residents of the Northeast. Participation rates were higher among widows, those with low educational attainment, and those with lower incomes.
Study Results

Patterns
Supplemental medical coverage was an important indicator of Part D enrollment. For example, 65 percent of those with a private medical supplement but no drug coverage in 2005 enrolled in Part D, as did 82 percent of those with other supplemental plans (Exhibit 2). 9 In contrast, only 51 percent of those with no supplemental Participation In The Low-Income Subsidy Exhibit 3 presents bivariate and multivariate results for low-income subsidy participation among low-income beneficiaries without drug coverage in 2005. Consistent with policy targets, those with greatest need, in terms of both socioeconomic disadvantage and poor health, were most likely to participate.
Disabled beneficiaries under age fifty, blacks, single people, those with the lowest educational attainment and incomes, and those reporting financial hardship were more likely than others to participate in a low-income subsidy plan. Those with private supplemental coverage were less likely to participate, while those with other supplemental medical plans were more likely to do so. Health status played an important role: Increasing numbers of self-reported conditions were associated with increased participation (see the online Appendix).
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Multivariate estimates were generally consistent with the bivariate results, although some effects, like education, were not significant when income and other socioeconomic characteristics were controlled for. As expected, higher Part D premiums were associated with higher lowincome subsidy enrollment. However, as with Part D enrollment, the magnitude of the effect was small.
Enrollment Of Vulnerable Beneficiaries The number of beneficiaries without drug coverage declined dramatically by the end of 2006. Yet the question remains as to whether Part D implementation was successful in enrolling the most vulnerable beneficiaries, and if not, why not. A quarter of all beneficiaries and a third of low-income beneficiaries met our criteria for high vulnerability. Part D enrollment rates were relatively high for the most vulnerable beneficiaries, and a similar difference existed among the low-income subgroup (Exhibit 4). Only 39 percent of low-income vulnerable beneficiaries, representing half of those enrolled in Part D, received the low-income subsidy.
Why did beneficiaries not enroll in Part D? The most vulnerable reported that premiums were too high, that they lacked knowledge about plans, or that they didn't understand how to enroll (Exhibit 5). Almost half of the less vulnerable reported that they didn't use enough prescription drugs to benefit.
Discussion
This article provides the first in-depth look at factors associated with early Part D enrollment among Medicare beneficiaries without prior prescription drug coverage. Overall, our results 
11-16
Our findings are also consistent with policy expectations that the neediest beneficiaries would be more likely to enroll in Part D and, if eligible, to take advantage of the "Extra Help" provided by the low-income subsidy. The finding Effect size is the change in the predicted probability of Part D low-income subsidy enrollment when the beneficiary has the designated attribute relative to the reference group (shown for each variable). Other attributes within each categorical variable are shown only when odds ratios (OR) with respect to the reference group were significantly different from 1 at alpha = 0.05 or lower. In cases where there are only two attributes under one variable, differences are reported in notes only. a Estimated OR significant at alpha = 0.01. b Estimated OR significant at alpha = 0.05.
c OR for urban compared to reference significantly different from 1 at the 0.01 level for percentage enrolled and at the 0.05 level for effects on probability.
d OR for 100 percent or less to reference is significantly different from 1 at the 0.01 level for percentage enrolled and at the 0.05 level for effects on probability.
that lower premiums were associated with higher total plan enrollment (and lower lowincome subsidy participation) is consistent with economic theory.
Differences By Vulnerability It is important to stress that our findings apply only to beneficiaries who reported no drug coverage in 2005. Although we did not explicitly address factors predicting lack of coverage in that year, our findings must be interpreted with an understanding of how selection might affect the observed results.
It is reasonable to assume that those without drug coverage prior to Part D constituted two distinct groups. 13 Members of one group likely had high demand for drug coverage, but preexisting health problems made private insurance unaffordable, while their incomes or assets were too high for them to qualify for public programs. The experience of this group is captured by our composite "vulnerable" designation. We expected near-universal enrollment in Part D within this group.
Members of a second group, comprising relatively healthy beneficiaries with low expected use of prescription medications, chose not to With these two scenarios of the vulnerable and nonvulnerable in mind, it is not surprising to find that a number of nonvulnerable beneficiaries continued to decline drug coverage. Almost half reported that they did not take enough prescription drugs to make participation worthwhile.Whether they are rational decision makers or myopic with respect to future needs and penalties can be debated. 12, 13 But in the short run, they are of minor concern for policy makers.
In contrast, we had expected that the overwhelming majority of beneficiaries designated as vulnerable would take up Part D coverage, and that the pattern would be particularly strong for low-income beneficiaries, who would be potentially eligible for the low-income subsidy. It is clear from our results that the vulnerable were more likely than others to participate in Part D. However, the fact that participation was far from universal among these beneficiaries suggests that barriers to enrollment remain.
Eligible But Not Enrolled The failure of many beneficiaries who are eligible for the lowincome subsidy to enroll has generated considerable public interest. Estimates from 2007 and 2008 survey data indicate that the problem has not diminished. [17] [18] [19] Policy researchers and advocates for the elderly have suggested dropping the low-income subsidy asset test-with thresholds at $7,500 for single adults and $12,000 for married couples in 2006-which would expand eligibility and simplify enrollment. Others have argued for lengthening the enrollment period and changing it from an opt-in process to one in which beneficiaries are automatically enrolled and must opt out of the system, as with Medicare Part B. 20, 21 The 2008 Medicare Improvements to Patients and Providers Act addressed certain barriers to participation by including additional funding for Medicare outreach and the elimination of penalties for late enrollment for beneficiaries who are or become eligible for the low-income subsidy. 22 Our results indicate that the effect of premiums on enrollment is small, which suggests that the penalty for late enrollment might not be a major deterrent and that eliminating the penalty might not have had large results.
Beginning in January 2010, Medicare no longer counts life insurance policies or direct help that other people provide toward a beneficiary's household bills as income, and there is now better coordination of applications for the lowincome subsidy and state-level Medicare Savings Programs. These new provisions extend eligibility and may marginally improve low-income subsidy take-up rates, but they fall well short of the liberalized eligibility criteria recommended by critics of the low-income subsidy program. The success of these more limited measures will need to be evaluated over time.
Effects 
Conclusion
Implementation of Part D clearly has had an important impact on drug coverage for those previously without it. However, the success of the program will ultimately depend on its impact on access to needed pharmaceuticals, reduced financial hardship, and improved health status. Preliminary evidence from a variety of studies suggests small increases in utilization and spending among Part D enrollees generally. [23] [24] [25] [26] Whether these changes result in improved health status is yet to be determined. Ongoing analyses involving new releases of the Medicare Current Beneficiary Survey, as well as other data sources from the Centers for Medicare and Medicaid Services, will help us monitor the health impacts of Part D, particularly for this vulnerable population. ▪ Funding for this research was provided by a grant from Novartis Pharmaceuticals Corporation.
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